日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical Trial

Tucidinostat Plus R-CHOP vs R-CHOP 治疗 MYC/BCL2 双表达弥漫性大 B 细胞淋巴瘤:一项随机临床试验

Xu, Peng-Peng; Song, Yu-Qin; Shen, Jian-Zhen; Cai, Qing-Qing; Zhou, Hui; Zhang, Li-Ling; Xiang, Ying; Sun, Xiu-Hua; Yang, Wei; Yao, Zhi-Hua; Jing, Hong-Mei; Wen, Shu-Juan; Jin, Jie; Xue, Hong-Wei; Cen, Hong; Ding, Kai-Yang; Jin, Zheng-Ming; Liu, Li-Hong; Xing, Xiao-Jing; Li, Lan-Fang; Hou, Ming; Liu, Lin; Zhang, Ming-Zhi; Li, Wen-Yu; Bai, Ou; Feng, Ru; Zhu, Zun-Min; Wu, Hui-Jing; Su, Li-Ping; Gao, Li; Li, Fei; Huang, Wen-Rong; Liu, Peng; Yan, Xiao-Jing; Zhao, Ying; Su, Hang; Zhao, Xie-Lan; Fu, Rong; Liu, Hong; Shi, Wen-Yu; Li, Hui-Zhi; Chen, Bo; Ning, Zhi-Qiang; Zhu, Jun; Zhao, Wei-Li

Signaling pathways and targeted interventions for precancers

癌前病变的信号通路和靶向干预

Yang, Jin; Wang, Shimeng; Li, Xin; Xu, Hongdan; Sun, Tongxu; Hu, Tao; Luo, Jingjing; Zhou, Hongmei

Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2 positive metastatic breast cancer: long term survival results from randomised phase 3 PHILA trial

吡咯替尼或安慰剂联合曲妥珠单抗和多西他赛治疗HER2阳性转移性乳腺癌:随机3期PHILA试验的长期生存结果

Ma, Fei; Yan, Min; Li, Wei; Ouyang, Quchang; Tong, Zhongsheng; Teng, Yuee; Wang, Yongsheng; Wang, Shusen; Geng, Cuizhi; Luo, Ting; Zhong, Jincai; Zhang, Qingyuan; Liu, Qiang; Zeng, Xiaohua; Sun, Tao; Mo, Qinguo; Zhou, Shoubing; Li, Peidong; Cheng, Jing; Wang, Xiaojia; Nie, Jianyun; Yang, Jin; Wu, Xinhong; Wang, Xinshuai; Li, Huiping; Yao, Guangyu; Fan, Yang; Lin, Jiaman; Zhu, Xiaoyu; Xu, Binghe

State-specific enhancer landscapes govern microglial plasticity.

特定状态的增强子图谱控制着小胶质细胞的可塑性。

Hamagami Nicole, Kapadia Dvita, Barclay Kia M, Huang Yanlong, Abduljawad Nora, Cheng Zuolin, McLaughlin Liam, Singhania Darsh, Ding Xukai, Yang Jin, Sun Zhixin, Karra Vikram, Du Siling, Bayguinov Peter, Yu Guoqiang, Li Yang E, Gabel Harrison W, Li Qingyun

Metallic molybdenum sulfide catalyses protometabolic carbon dioxide reaction networks under extreme conditions

金属硫化钼在极端条件下催化原始代谢二氧化碳反应网络

Chen, Pengfei; Liu, Xu; He, Daoping; Liao, Yiju; Li, Haozhe; Cheng, Jiong; Lu, Yichang; Yang, Ziming; Yang, Yang; Jin, Fangming

From the same supramolecular framework to distinct types of porous liquids via in-situ transformation

通过原位转化,从相同的超分子框架构建不同类型的多孔液体

Liu, Yang; Jin, Han-Yan; Li, Meng-Meng; Yang, Tao; Zuo, Mingrui; Li, Chenrui; Ding, Lifeng; Sun, Lin-Bing

Osimertinib with or without savolitinib as first-line treatment for MET-aberrant, EGFR-mutant NSCLC: randomized phase 2 trial (FLOWERS)

奥希替尼联合或不联合沙沃替尼作为MET异常、EGFR突变型非小细胞肺癌的一线治疗:随机2期试验(FLOWERS)

Li, Anna; Feng, Wei-Neng; Li, Juan; Xu, Bing-Fei; Zhao, Jun; Jia, Yun; Tang, Ke-Jing; Li, Yong-Sheng; Zhou, Cheng-Zhi; Fan, Yun; Xu, Chong-Rui; Sun, Yue-Li; Chen, Hua-Jun; Yan, Hong-Hong; Shi, Zong-Kun; Yang, Jin-Ji

OVOCs drive radical cycling and ozone formation in background air

OVOCs 会驱动背景空气中的自由基循环和臭氧生成

Xiong, Enyu; Guo, Hai; Fu, Tzung-May; Lyu, Xiaopu; Wang, Yu; Zhou, Beining; Xia, Men; Zou, Zhouxing; Yuan, Qi; Yang, Jin; Shek, Kit Ying; Chen, Jiongkai; Jiang, Tianci; Tao, Wei; Zhang, Aoxing; Xiang, Wang; Lee, Shuncheng; Wang, Tao

XPC Deficiency Activate Cisplatin-Mediated Autophagy in Bladder Cancer by Limiting Novel PHRF1-Mediated Ubiquitination of the p53 Protein

XPC缺陷通过限制新型PHRF1介导的p53蛋白泛素化,激活膀胱癌中顺铂介导的自噬。

Zhao, Baixiong; Huang, Yaqin; Shi, Jiazhong; Zhou, Xiaozhou; Fagman, Johan Bourghardt; Wang, Liwei; Liu, Sha; Wang, Wuxing; Liu, Yuting; Chen, Zhiwen; Yang, Jin

Two Distinct Phonon Wave Effects Control Thermal Transport across the Coherent-Incoherent Regime in Superlattices

两种不同的声子波效应控制着超晶格相干-非相干区域的热输运

Yang, Jin; Zhu, Jingyi; McGaughey, Alan J H; Ong, Wee-Liat